The Oral-THC Study Tested Verbal Memory Once, 80 Minutes After Dosing

The oral-THC laboratory study’s memory result came from one scheduled assessment at 80 minutes. It did not track verbal memory continuously across the entire drug-effect period.

Memory had a different schedule from other outcomes

Participants received 10 milligrams of oral dronabinol or placebo. Subjective measures and heart rate were repeated during the day, while the Rey Auditory Verbal Learning Test was administered once per test day. Immediate and delayed recall components belonged to that assessment, rather than separate challenges covering every later hour.

The null result keeps that timing limitation

The reported recall outcomes showed no significant dose, sex or interaction effects. This supports a bounded conclusion about these measurements under this protocol. It does not demonstrate unchanged memory before testing, later in the day or at the individual’s strongest subjective effect.

Do not substitute a subjective peak for the memory time

Oral THC effects vary in onset and timing. Repeated subjective measurements could identify a peak at a different point from the memory assessment. The study did not establish that each person’s memory test coincided with their own peak exposure or strongest response. For a functional opinion, retain the dose, route, test and elapsed time. A single negative comparison cannot certify an entire day of unaffected performance or readiness for a driving task the experiment did not measure.

Related analysis: the trial’s main results and limitations.

Research cited

Aghaei and colleagues (2024). Sex Differences in the Acute Effects of Oral THC: A Randomized, Placebo-Controlled, Crossover Human Laboratory Study.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

The CBD Scan Trial Used Equal Allocation Despite Planning a Two-to-One Ratio

The scan-anxiety study ultimately randomized twenty-five participants to each treatment. The paper disclosed that its original sample-size plan anticipated a two-to-one allocation instead. The discrepancy concerned the allocation ratio The central registrar inadvertently implemented a one-to-one scheme rather than the originally intended unequal ratio. Participants still underwent randomized assignment, and…

Spread the love

Read Article: The CBD Scan Trial Used Equal Allocation Despite Planning a Two-to-One Ratio

Only Six Participants Had Severe Baseline Anxiety in the CBD Scan Trial

The scan-anxiety trial stratified randomization by baseline anxiety severity, but only six participants were in its severe category. Stratification did not supply enough data for a reliable severe-anxiety subgroup analysis. The strata helped organize allocation Participants were assigned within GAD-7 categories covering mild-to-moderate and severe anxiety. Of the fifty women…

Spread the love

Read Article: Only Six Participants Had Severe Baseline Anxiety in the CBD Scan Trial

The CBD Scan-Anxiety Trial Measured Prescan Anxiety, Not Anxiety During the Scan

The trial’s acute anxiety assessment occurred after CBD dosing but generally before the scheduled cancer scan. It did not directly measure whether CBD reduced distress inside the scanner. The two timing intervals were different Participants received the study drug within 48 hours before a tumor-assessment scan. Anxiety was reassessed two…

Spread the love

Read Article: The CBD Scan-Anxiety Trial Measured Prescan Anxiety, Not Anxiety During the Scan

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us